AbstractActivation of the transforming growth factor (TGF) α/epidermal growth factor receptor (EGFR)-mediated signaling pathway is a common mechanism for dysregulated growth of head and neck squamous cell carcinoma (HNSCC). c-Cbl-interacting protein of 85 kDa (CIN85) is an adaptor protein that facilitates EGFR internalization. Little is known, however, about a role of CIN85 in EGFR signaling as well as its relevance to tumor development and progression of HNSCC. Here, we demonstrate that CIN85 is highly expressed in HNSCC tumor samples compared with adjacent normal tissues, and this overexpression is significantly correlated with advanced clinical stage. The experiments using CIN85-overexpressing and knockdown HNSCC cell lines showed that C...
Head and neck squamous cell carcinoma (HNSCC) is characterized by the overexpression of the epiderma...
Abstract Recent advances in genomics, proteomics, bioinformatics and systems biology h...
Head and neck squamous cell carcinoma (HNSCC) is a highly morbid disease. Recent developments includ...
AbstractActivation of the transforming growth factor (TGF) α/epidermal growth factor receptor (EGFR)...
Activation of the transforming growth factor (TGF) α/epidermal growth factor receptor (EGFR)-mediate...
AbstractThe development of head and neck squamous cell carcinoma (HNSCC) involves the accumulation o...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the United States a...
The epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of head and neck s...
AbstractEpidermal growth factor receptor (EGFR) is an important oncoprotein that promotes cell growt...
<div><p>The epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of head an...
Background: Mounting evidence suggests that recurrence of resected head and neck squamous cell carci...
Transactivation of the epidermal growth factor receptor (EGFR) represents the paradigm for cross-tal...
AbstractOverexpression of the epidermal growth factor receptor (EGFR, ErbB1, HER1) is frequent in he...
[[abstract]]Head and neck squamous cell carcinoma (HNSCC), the most common malignant neoplasm arisin...
The development of head and neck squamous cell carcinoma (HNSCC) involves the accumulation of geneti...
Head and neck squamous cell carcinoma (HNSCC) is characterized by the overexpression of the epiderma...
Abstract Recent advances in genomics, proteomics, bioinformatics and systems biology h...
Head and neck squamous cell carcinoma (HNSCC) is a highly morbid disease. Recent developments includ...
AbstractActivation of the transforming growth factor (TGF) α/epidermal growth factor receptor (EGFR)...
Activation of the transforming growth factor (TGF) α/epidermal growth factor receptor (EGFR)-mediate...
AbstractThe development of head and neck squamous cell carcinoma (HNSCC) involves the accumulation o...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the United States a...
The epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of head and neck s...
AbstractEpidermal growth factor receptor (EGFR) is an important oncoprotein that promotes cell growt...
<div><p>The epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of head an...
Background: Mounting evidence suggests that recurrence of resected head and neck squamous cell carci...
Transactivation of the epidermal growth factor receptor (EGFR) represents the paradigm for cross-tal...
AbstractOverexpression of the epidermal growth factor receptor (EGFR, ErbB1, HER1) is frequent in he...
[[abstract]]Head and neck squamous cell carcinoma (HNSCC), the most common malignant neoplasm arisin...
The development of head and neck squamous cell carcinoma (HNSCC) involves the accumulation of geneti...
Head and neck squamous cell carcinoma (HNSCC) is characterized by the overexpression of the epiderma...
Abstract Recent advances in genomics, proteomics, bioinformatics and systems biology h...
Head and neck squamous cell carcinoma (HNSCC) is a highly morbid disease. Recent developments includ...